01 1Xellia Pharmaceuticals ApS
01 1GRAMICIDIN, USP
01 1Denmark
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-27
Pay. Date : 2012-11-15
DMF Number : 17538
Submission : 2004-07-12
Status : Active
Type : II
20
Xellia Pharmaceuticals Ltd, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GRAMICIDIN, USP, with a corresponding US DMF Number 17538.
Remarkably, this DMF maintains an Active status since its submission on July 12, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 27, 2013, and payment made on November 15, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
